Compared with COL1A2 mutations, COL1A1 mutations were more frequent in the patients with OI type I (46 % vs. 33 %) and III (14 % vs. 11 %), and less frequent in the patients with OI type IV (39 % vs. 56 %). This evidence concerns the gene COL1A1 and osteogenesis imperfecta type 4.